David Toung
Stock Analyst at Argus Research
(4.50)
# 1,013
Out of 4,382 analysts
334
Total ratings
61.9%
Success rate
8.4%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Maintained: Buy | $310 | $265.15 | +16.91% | 3 | Jun 2, 2026 | |
| IQV IQVIA Holdings | Maintained: Buy | n/a | $183.45 | - | 5 | May 29, 2026 | |
| EW Edwards Lifesciences | Maintained: Buy | n/a | $85.96 | - | 2 | May 21, 2026 | |
| PFE Pfizer | Maintained: Buy | $35 | $26.04 | +34.41% | 12 | May 6, 2026 | |
| BSX Boston Scientific | Rated: Buy | $130 → $95 | $48.55 | +95.67% | 10 | Apr 24, 2026 | |
| DHR Danaher | Rated: Buy | $265 → $230 | $184.30 | +24.80% | 5 | Apr 23, 2026 | |
| UNH UnitedHealth Group | Upgraded: Buy | $400 | $399.47 | +0.13% | 14 | Apr 21, 2026 | |
| IART Integra LifeSciences Holdings | Downgraded: Hold | n/a | $16.99 | - | 6 | Apr 15, 2026 | |
| MDT Medtronic | Maintained: Buy | $115 | $81.67 | +40.81% | 18 | Apr 6, 2026 | |
| BDX Becton, Dickinson and Company | Rated: Buy | $290 → $180 | $151.16 | +19.08% | 16 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $280 → $400 | $275.04 | +45.43% | 19 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $180 | $149.16 | +20.68% | 3 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $110 → $95 | $64.67 | +46.90% | 3 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $81.01 | - | 3 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $350.08 | - | 21 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $65 → $68 | $51.99 | +30.79% | 10 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $200 | $181.34 | +10.29% | 11 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $610 | $472.80 | +29.02% | 9 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $210 | $232.77 | -9.78% | 13 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $570 → $775 | $775.66 | -0.09% | 15 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $415.53 | - | 5 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $150 | $91.07 | n/a | 12 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $7.05 | n/a | 5 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $410 → $450 | $305.66 | n/a | 11 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $165 → $175 | $200.29 | n/a | 2 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $882.34 | n/a | 1 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $372.13 | n/a | 4 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $450 → $520 | $422.06 | n/a | 8 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $150 | $87.33 | n/a | 15 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $665 → $770 | $1,131.42 | n/a | 9 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $265 → $300 | $349.58 | n/a | 5 | Nov 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 → $125 | $120.79 | n/a | 10 | Jun 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $75 | $129.16 | n/a | 11 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $57.27 | n/a | 6 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 → $140 | $227.23 | n/a | 14 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $205.71 | n/a | 10 | Aug 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $195.34 | n/a | 1 | Feb 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $19 | $5.00 | n/a | 3 | Oct 21, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $19.38 | n/a | 3 | Aug 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $21 | $43.43 | n/a | 1 | Apr 5, 2016 |
Labcorp Holdings
Jun 2, 2026
Maintained: Buy
Price Target: $310
Current: $265.15
Upside: +16.91%
IQVIA Holdings
May 29, 2026
Maintained: Buy
Price Target: n/a
Current: $183.45
Upside: -
Edwards Lifesciences
May 21, 2026
Maintained: Buy
Price Target: n/a
Current: $85.96
Upside: -
Pfizer
May 6, 2026
Maintained: Buy
Price Target: $35
Current: $26.04
Upside: +34.41%
Boston Scientific
Apr 24, 2026
Rated: Buy
Price Target: $130 → $95
Current: $48.55
Upside: +95.67%
Danaher
Apr 23, 2026
Rated: Buy
Price Target: $265 → $230
Current: $184.30
Upside: +24.80%
UnitedHealth Group
Apr 21, 2026
Upgraded: Buy
Price Target: $400
Current: $399.47
Upside: +0.13%
Integra LifeSciences Holdings
Apr 15, 2026
Downgraded: Hold
Price Target: n/a
Current: $16.99
Upside: -
Medtronic
Apr 6, 2026
Maintained: Buy
Price Target: $115
Current: $81.67
Upside: +40.81%
Becton, Dickinson and Company
Mar 20, 2026
Rated: Buy
Price Target: $290 → $180
Current: $151.16
Upside: +19.08%
Mar 17, 2026
Reiterated: Buy
Price Target: $280 → $400
Current: $275.04
Upside: +45.43%
Mar 11, 2026
Upgraded: Buy
Price Target: $180
Current: $149.16
Upside: +20.68%
Mar 3, 2026
Rated: Buy
Price Target: $110 → $95
Current: $64.67
Upside: +46.90%
Dec 12, 2025
Maintained: Buy
Price Target: n/a
Current: $81.01
Upside: -
Dec 8, 2025
Maintained: Hold
Price Target: n/a
Current: $350.08
Upside: -
Nov 20, 2025
Rated: Buy
Price Target: $65 → $68
Current: $51.99
Upside: +30.79%
Nov 17, 2025
Upgraded: Buy
Price Target: $200
Current: $181.34
Upside: +10.29%
Oct 28, 2025
Maintained: Buy
Price Target: $610
Current: $472.80
Upside: +29.02%
Oct 14, 2025
Maintained: Buy
Price Target: $210
Current: $232.77
Upside: -9.78%
Aug 20, 2025
Rated: Buy
Price Target: $570 → $775
Current: $775.66
Upside: -0.09%
Jul 21, 2025
Downgraded: Hold
Price Target: n/a
Current: $415.53
Upside: -
Apr 21, 2025
Maintained: Buy
Price Target: $150
Current: $91.07
Upside: n/a
Mar 26, 2025
Maintained: Hold
Price Target: n/a
Current: $7.05
Upside: n/a
Feb 3, 2025
Maintained: Buy
Price Target: $410 → $450
Current: $305.66
Upside: n/a
Oct 24, 2024
Maintained: Buy
Price Target: $165 → $175
Current: $200.29
Upside: n/a
Aug 15, 2024
Rated: Buy
Price Target: n/a
Current: $882.34
Upside: n/a
Aug 1, 2024
Maintained: Buy
Price Target: n/a
Current: $372.13
Upside: n/a
Jul 23, 2024
Maintained: Buy
Price Target: $450 → $520
Current: $422.06
Upside: n/a
May 20, 2024
Upgraded: Buy
Price Target: $150
Current: $87.33
Upside: n/a
Feb 7, 2024
Maintained: Buy
Price Target: $665 → $770
Current: $1,131.42
Upside: n/a
Nov 6, 2023
Maintained: Buy
Price Target: $265 → $300
Current: $349.58
Upside: n/a
Jun 6, 2023
Maintained: Buy
Price Target: $115 → $125
Current: $120.79
Upside: n/a
Jan 28, 2022
Upgraded: Buy
Price Target: $75
Current: $129.16
Upside: n/a
Nov 1, 2021
Downgraded: Hold
Price Target: n/a
Current: $57.27
Upside: n/a
Aug 5, 2021
Maintained: Buy
Price Target: $115 → $140
Current: $227.23
Upside: n/a
Aug 27, 2019
Downgraded: Hold
Price Target: n/a
Current: $205.71
Upside: n/a
Feb 16, 2018
Downgraded: Hold
Price Target: n/a
Current: $195.34
Upside: n/a
Oct 21, 2016
Reiterated: Buy
Price Target: $17 → $19
Current: $5.00
Upside: n/a
Aug 15, 2016
Maintained: Hold
Price Target: n/a
Current: $19.38
Upside: n/a
Apr 5, 2016
Downgraded: Hold
Price Target: $21
Current: $43.43
Upside: n/a